智通财经APP讯，再升科技(603601.SH)发布公告，公司股票于2025年12月5日、12月8日、12月9日连续 三个交易日内收盘价格涨幅偏离值累计超过20%，根据《上海证券交易所交易规则》的有关规定，属于 股票交易异常波动情形。公司关注到有市场信息讨论公司向SpaceX供货相关事项。目前公司主要业务 为以微纤维玻璃棉为核心材料，开发"干净空气材料"、"高效节能材料"和"无尘空调产品"，应用于"工 业空间、移动空间、生活空间"三大空间。经公司自查核实，公司高效节能材料中用于航空航天领域的 产品2024年度收入占公司营收比例不到0.5%;其中，公司自2020年起向国际某知名航天公司直接供应"高 硅氧纤维产品"，2024年该项产品业务收入占公司总营收比例极低，对公司业绩无重大影响，目前"高硅 氧纤维产品"暂无在手订单。 ...

格隆汇12月10日｜再升科技(603601.SH)公告称，公司股东郭茂拟以协议转让方式向中融华信国际生物 科技（北京）有限责任公司转让其持有的公司62,187,200股无限售条件流通股，占公司总股本的 6.04%。本次权益变动后，郭茂及其一致行动人合计持有公司股份将减少至281,216,808股，占公司总股 本的比例由33.34%变为27.30%。本次权益变动尚需取得上海证券交易所出具的股份转让申请确认书， 并在中国证券登记结算有限责任公司上海分公司办理股份过户登记手续。 ...

再升科技公告称，公司股票于2025年12月5日、8日、9日连续三个交易日内收盘价格涨幅偏离值累计超 20%，属异常波动，10日继续涨停。截至10日收盘，市盈率（LYR）为79.00倍，市盈率（TTM）为 66.18倍，高于行业平均。公司日常经营正常，无应披露未披露重大信息。控股股东郭茂正筹划协议转 让部分股份，尚需履行相关程序，结果不确定。此外，公司自查显示，2024年航空航天领域产品收入占 营收不到0.5%，向国际某知名航天公司供应的"高硅氧纤维产品"收入极低，目前无在手订单。 ...

New Stock Listings - Baiaosaitu (688796) listed at an issue price of 26.68 on December 10, 2025[1] - Quanyin Gaoke (300087) has a tender offer period from December 4, 2025, to January 5, 2026[1] - Tiangong Co. (605255) has a tender offer period from November 20, 2025, to December 19, 2025[1] Delisting and Trading Alerts - ST Guangdao (920680) enters the delisting arrangement period starting December 11, 2025[1] - ST Suwu (600200) has 13 trading days remaining until the last trading day[1] Market Volatility - Hai Xin Food (002702) reported severe abnormal fluctuations[1] - Anji Food (603696) and other companies are under observation for abnormal trading activities[2] Additional Announcements - Multiple companies including Dongbai Group (600693) and Nanjing Business Travel (600250) have recent announcements linked to their stock codes[1] - Various companies are linked to announcements regarding abnormal fluctuations and trading activities[3]

中国经济网北京12月10日讯 再升科技(603601.SH)昨晚发布关于公司控股股东拟协议转让公司部分 股份的公告。公司控股股东郭茂（以下简称：转让方或控股股东）与中融华信国际生物科技（北京）有 限责任公司（以下简称：受让方或中融华信）于2025年12月8日签订了《股份转让协议》，郭茂拟通过 协议转让方式向中融华信转让其持有的62,187,200股无限售条件流通股（占公司11月28日总股本 1,030,143,430股的6.04%），转让总价款为人民币343,895,216元。 本次协议转让过户前，受让方未持有公司股份；本次协议转让过户后，受让方将持有公司无限售条 件流通股62,187,200股，占公司总股本比例为6.04%，成为持有公司5%以上股份的股东。 本次转让事项尚需上海证券交易所合规性审核，并在中国证券登记结算有限责任公司上海分公司办 理协议股份过户登记手续，能否最终完成实施尚存在不确定性。敬请广大投资者理性投资，注意投资风 险。 本次协议转让事项的受让方承诺自标的股份过户登记至其名下之日起十二个月内不会减持标的股 份。 本次协议转让未触及要约收购，不会导致公司控股股东及实际控制人发生变化，不会对公 ...

中国经济网北京12月10日讯再升科技（603601）(603601.SH)昨晚发布关于公司控股股东拟协议转让公 司部分股份的公告。公司控股股东郭茂(以下简称：转让方或控股股东)与中融华信国际生物科技(北京) 有限责任公司(以下简称：受让方或中融华信)于2025年12月8日签订了《股份转让协议》，郭茂拟通过 协议转让方式向中融华信转让其持有的62,187,200股无限售条件流通股(占公司11月28日总股本 1,030,143,430股的6.04%)，转让总价款为人民币343,895,216元。 本次协议转让过户前，受让方未持有公司股份；本次协议转让过户后，受让方将持有公司无限售条件流 通股62,187,200股，占公司总股本比例为6.04%，成为持有公司5%以上股份的股东。 本次转让事项尚需上海证券交易所合规性审核，并在中国证券登记结算有限责任公司上海分公司办理协 议股份过户登记手续，能否最终完成实施尚存在不确定性。敬请广大投资者理性投资，注意投资风险。 经计算，郭茂已累计套现5.35亿元。 据新浪财经9月26日消息，郭茂从2018年1月26日起，第一次减持再升科技股份，迄今为止，累计减持公 司股票3744.0 ...

新京报贝壳财经讯 12月9日，再升科技发布公告称，公司控股股东郭茂与中融华信国际生物科技（北 京）有限责任公司（简称"中融华信"）签订了《股份转让协议》，郭茂拟通过协议转让方式向中融华信 转让其持有的6218.72万股无限售条件流通股（占公司11月28日总股本的6.04%），转让总价款为3.44亿 元。本次协议转让过户后，受让方将持有公司无限售条件流通股6218.72万股，占公司总股本比例为 6.04%，成为持有公司5%以上股份的股东。 ...

一、【早盘盘面回顾】 智通财经12月10日讯，市场早盘震荡调整，沪指低开低走，创业板指跌超1%。量能再度萎缩，沪深两 市半日成交额1.14万亿，较上个交易日缩量1184亿。全市场超3800只个股下跌。从板块来看，海南板块 走强，罗牛山、海南瑞泽涨停。零售概念表现活跃，永辉超市、南京商旅双双3连板。商业航天板块局 部强势，再升科技3连板，天通股份2连板。多只福建人气股下挫，海欣食品触及跌停，招标股份、红相 股份大跌。截至收盘，沪指跌0.72%，深成指跌0.56%，创业板指跌1.23%。 个股来看，今日早盘涨停数量为37家（不包括ST及未开板新股），炸板率为43%，连板股数量为15家， 厦门港务、昇兴股份、东百集团4连板，博纳影业、安妮股份、南京商旅、永辉超市、再升科技3连板， 信隆健康、跃岭股份、欣贺股份、中央商场、美凯龙2连板。 另外需注意的是，摩尔线程今日涨超19%，成功突破上市首日高点，截至午盘成交额达70.3亿。 | C摩尔-U(688795) | | --- | | 750.00 所属行业: | | | | | | 查看所属板块 > | | --- | --- | --- | --- | --- | ...

下载财联社APP获取更多资讯 准确 快速 权威 专业 7x24h电报 头条新闻 VIP资讯 实时盯盘 今日早盘，A股市场震荡调整，沪指低开低走，创业板指跌超1%。量能再度萎缩，沪深两市半日成交额1.14万亿，较上个交易日缩量1184亿。全市场 超3800只个股下跌。 从板块来看， 海南板块走强， 罗牛山、海南瑞泽涨停。零售概念表现活跃，永辉超市、南京商旅双双3连板。商业航天板块局部强势，再 升科技3连板，天通股份2连板。多只福建人气股下挫，海欣食品触及跌停，招标股份、红相股份大跌。 板块方面， 海南、贵金属、零售、影视院线等板块涨幅居前， 培育钻石、光伏等板块跌幅居前。截至收盘，沪指跌0.72%，深成指跌 0.56%，创业板指跌1.23%。 ...

Group 1 - Jinggong Technology signed a sales contract with Hubei Yuchuang worth 729 million yuan, accounting for 42.16% of the company's audited revenue for 2024 [1] - Heshun Electric is expected to win a bid for a State Grid procurement project worth 107 million yuan, representing 24.97% of the company's 2024 revenue [2] - Yongmaotai plans to invest approximately 400 million yuan in a new intelligent manufacturing project for magnesium-aluminum alloy materials [3] Group 2 - Longi Green Energy announced the termination of its plan to issue global depositary receipts abroad, stating it will not significantly impact its operations [4] - Bai Ao Intelligent is expected to win bids for projects totaling 27.5 million yuan [5] - Lian Biological is planning a change of control and asset purchase, leading to a temporary suspension of its stock [6] Group 3 - Bo Rui Communication intends to acquire 51% of Meijing Technology for 66.49 million yuan [7] - Huitai Medical plans to repurchase shares worth 200 to 250 million yuan for employee stock ownership plans [8] - Yifang Biological is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange [9] Group 4 - Jiuqiang Biological's shareholders signed an agreement for the transfer of 5% of the company's shares to China National Pharmaceutical Investment [11] - Songcheng Performing Arts plans to repurchase shares worth 100 to 200 million yuan for capital reduction [12] - Zhonghong Medical's subsidiary is expected to be selected for a centralized procurement project in Jiangxi Province [13] Group 5 - Xingfu Electronics plans to invest 480 million yuan in a new electronic-grade phosphoric acid project [14] - Jiaao Environmental Protection's stock will be subject to risk warnings due to an administrative penalty [15] - ST Nuotai received a drug registration certificate for a new injection [16] Group 6 - Haimo Technology plans to sell its controlling subsidiary, Xian Sitian Instrument, for 370 million yuan [17] - Jingce Electronics signed multiple sales contracts with a single customer totaling 433 million yuan [18] - Donghua Testing's controlling shareholder plans to reduce its stake by up to 1.99% [19][20] Group 7 - Xingqi Eye Medicine completed the first subject enrollment for a Phase II clinical trial of its eye drop product [21] - Kute Intelligent's controlling shareholder plans to reduce its stake by up to 2% [22] - Dongcheng Pharmaceutical's subsidiary received approval for a new specification of a heparin sodium injection [23] Group 8 - Zhaoyi Innovation is in the process of issuing H-shares and has received regulatory approval [24] - Aokang International's shareholder plans to reduce its stake by up to 3% [25] - Jiamei Packaging's controlling shareholder is planning a change of control, leading to a temporary stock suspension [26] Group 9 - ST Kevin's stock will have its risk warning lifted and will resume trading [27] - Zaiseng Technology's controlling shareholder plans to transfer 6.04% of the company's shares [28] - Lide New Energy's shareholder plans to reduce its stake by up to 1% [29] Group 10 - Srypu terminated its plan to acquire shares and will resume trading [30] - Longjiang Transportation's subsidiary plans to invest 2.679 billion yuan in a graphite mining project [31] - Haowei Group's controlling shareholder has not reduced its stake and has terminated the reduction plan [32] Group 11 - Huilun Crystal received an administrative penalty notice for information disclosure violations [33] - Haiguang Information terminated a major asset restructuring plan [34] - Zhongke Shuguang announced a cash dividend plan [35] Group 12 - Fushuo Technology's share purchase plan was approved by the Shenzhen Stock Exchange [36] - Dongbai Group's shareholder reduced its stake by 25.95 million shares [38]